Trial · NCT00414908
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperglycaemic conditions NEC | Metabolism and nutrition disorders | Pancrelipase (DB) | 1 | 24 | |
| other | Hyperglycaemic conditions NEC | Metabolism and nutrition disorders | Placebo (DB) | 2 | 28 | |
| other | Hyperglycaemic conditions NEC | Metabolism and nutrition disorders | Pancrelipase (OL) | 0 | 51 | |
| other | Upper respiratory Tract infections | Infections and infestations | Pancrelipase (DB) | 0 | 24 | |
| other | Upper respiratory Tract infections | Infections and infestations | Placebo (DB) | 0 | 28 | |
| other | Upper respiratory Tract infections | Infections and infestations | Pancrelipase (OL) | 4 | 51 | |
| serious | Acute and Chronic Pancreatitis | Gastrointestinal disorders | Pancrelipase (DB) | 0 | 24 | |
| serious | Acute and Chronic Pancreatitis | Gastrointestinal disorders | Placebo (DB) | 0 | 28 | |
| serious | Acute and Chronic Pancreatitis | Gastrointestinal disorders | Pancrelipase (OL) | 1 | 51 | |
| serious | Lower Limb Fractures and dislocations | Injury, poisoning and procedural complications | Pancrelipase (DB) | 0 | 24 | |
| serious | Lower Limb Fractures and dislocations | Injury, poisoning and procedural complications | Placebo (DB) | 0 | 28 | |
| serious | Lower Limb Fractures and dislocations | Injury, poisoning and procedural complications | Pancrelipase (OL) | 1 | 51 | |
| serious | Thermal Burns | Injury, poisoning and procedural complications | Pancrelipase (DB) | 0 | 24 | |
| serious | Thermal Burns | Injury, poisoning and procedural complications | Placebo (DB) | 0 | 28 | |
| serious | Thermal Burns | Injury, poisoning and procedural complications | Pancrelipase (OL) | 1 | 51 | |
| serious | Diabetes Mellitus (Incl Subtypes) | Metabolism and nutrition disorders | Pancrelipase (DB) | 0 | 24 | |
| serious | Diabetes Mellitus (Incl Subtypes) | Metabolism and nutrition disorders | Placebo (DB) | 0 | 28 | |
| serious | Diabetes Mellitus (Incl Subtypes) | Metabolism and nutrition disorders | Pancrelipase (OL) | 2 | 51 | |
| serious | Diabetic Complication Dermal | Metabolism and nutrition disorders | Pancrelipase (DB) | 0 | 24 | |
| serious | Diabetic Complication Dermal | Metabolism and nutrition disorders | Placebo (DB) | 0 | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00414908/events